Address And Details

333 S Hope St , Los Angeles, CA 90071
Fund Manager Team Managed
Manager Tenure

Strategy And Objective

The fund s investment objective is to achieve long-term growth of capital and income. The fund seeks to invest primarily in common stocks of companies that appear to offer superior opportunities for capital growth and most of which have a history of paying dividends. In addition, the fund may invest significantly in securities of issuers domiciled outside the United States. The investment adviser uses a system of multiple portfolio managers in managing the fund s assets. Under this approach, the portfolio of the fund is divided into segments managed by individual managers. The fund relies on the professional judgment of its investment adviser to make decisions about the fund s portfolio investments. The basic investment philosophy of the investment adviser is to seek to invest in attractively valued companies that, in its opinion, represent good, long-term investment opportunities. Securities may be sold when the investment adviser believes that they no longer represent relatively attractive investment opportunities.

Net Asset Value

as of 5:14 PM ET 09/17/2021

Performance

  • 1 Week
  • -0.36%
  • 1 Month
  • +0.32%
  • 3 Months
  • +2.97%
  • 1 Yr Return
  • +26.88%
  • 5 Yr Return
  • +46.92%

Equity Sector Breakdown

Technology 25.29%
Finance 17.32%
NonDurables 15.06%
IndustrialCyclical 12.17%
RetailTrade 7.93%
Health 6.77%
Utilities 3.13%
Energy 2.97%
Services 2.71%
ConsumerDurables 0.83%

Asset Allocation

Asset Type % Of Allocation
Stocks 98.06%
ForeignStocks 19.06%
Convertible 0.32%
Preferred 0.02%
Cash 0.00%
Bonds 0.00%
Other 0.00%
ForeignBonds 0.00%
ForeignHedged 0.00%
Total Net Assets 785.16 M

Risk Measures

Criteria 3 Years 5 Years 10 Years
Alpha -2.76 -3.05 -2.58
Beta 0.97 0.96 0.99
R Squared 0.97 0.95 0.95
Std Deviation 18.20 14.87 13.58
Sharpe Ratio 0.82 0.93 n/a

Purchase Information

as of 5:22 PM ET 09/16/2021
Minimum Initial $250
Minimum Additional $50
Minimum Initial IRA $25

Performance

Timeframe Average Annual Current Performance Monthly As Of 08/31/2021 Average Annual Current Performance Quarterly As Of 06/30/2021 Avg Annual Current Performance Monthly As Of 08/31/2021 Avg Annual Current Performance Quarterly As Of 06/30/2021
1 Year
  • +29.35%
  • +37.96%
+29.35% +37.96%
3 Year
  • +14.30%
  • +14.37%
+14.30% +14.37%
10 Year
  • +13.85%
  • +12.40%
+13.85% +12.40%
Life Of Fund
  • +9.37%
  • +9.26%
+9.37% +9.26%

Top 10 Holdings

Symbol Company Name % Of Assets
MSFT MICROSOFT CORP 4.91%
AVGO BROADCOM INC 4.04%
FB FACEBOOK INC 3.47%
AMZN AMAZON COM INC 2.32%
CMCSA COMCAST CORP 1.89%
PM PHILIP MORRIS INTERNATIONAL 1.86%
GOOGL ALPHABET INC CLASS A 1.68%
NFLX NETFLIX COM INC 1.55%
MO ALTRIA GROUP INC 1.52%
UNH UNITEDHEALTH GROUP INC 1.46%

Recent Articles from TheStreet

9/11 Lead

Cramer’s Recollections of 9/11

A beautiful day in New York City, Then the Unimaginable

Hong Kong Stocks Slump On Tech Sector Worries As US Official Signals Flaws In China Trade Deal

Intraday Reversals Signal Struggles for Market

But James "Rev Shark" Deporre says the trading action is both normal, and appropriate for September, and he's been adding some names to his portfolio.

stocks market index sh

Cramer's Mad Money Recap: FedEx, Costco, Nike

Jim Cramer says this is a rough season for stock, and investors need to take defensive action.

anxiety grocery mask sh

Jensen: Economy Has a Bearish Outlook

Real Money's Bret Jensen says a slower-than-expected pandemic recovery is a warning for the stock market.

Pfizer vaccine Lead

FDA Panel Recommends Covid Booster Shots for 65, Older and Those at High Risk

Food and Drug Administration's advisory panel on Friday voted to recommend Covid-19 booster shots of the Pfizer vaccine for a limited section of the population.

Ford Lead

Stock Market Today With Jim Cramer: How to Trade Ford

Jim Cramer discusses Ford and the impact of the impending tax policy changes on the stock market.

Jim Cramer: Stay Long Thermo Fisher, Sell FEI

Thermo Fisher Climbs on Strong 2022 Guidance

Thermo Fisher expects revenue to increase 12% year over year next year to $40.3 billion.